Acro Biomedical Co., Ltd. (ACBM)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -147.48 Thousand | 299.33 Thousand | -199.46 Thousand | -59.7 Thousand | -140.41 Thousand | -463.34 Thousand |
| Net Income | -15.87 Million | -7.69 Million | -117.45 Thousand | -371.6 Thousand | 419.66 Thousand | -2248.00 |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | -53.13 Thousand | - | - |
| Stock-based compensation | 15.71 Million | 7.65 Million | - | 148.39 Thousand | 7411.00 | - |
| Change in working capital | 9856.00 | 341.29 Thousand | -89 Thousand | 216.76 Thousand | -571.15 Thousand | -461.09 Thousand |
| Other non-cash items | 1706.00 | 4450.00 | 6997.00 | -132.00 | 3663.00 | 430.59 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 1.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 58.08 Thousand | -222.21 Thousand | 216.67 Thousand | 23.01 Thousand | 104.75 Thousand | 497.62 Thousand |
| Debt repayment | -58.08 Thousand | -222.21 Thousand | -216.67 Thousand | -186.33 Thousand | -500.00 | -2379.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 500 Thousand |
| Other Financing Activities | 58.08 Thousand | -222.21 Thousand | 216.67 Thousand | 209.35 Thousand | 105.25 Thousand | -2379.00 |
| Accounts receivables | -40.5 Thousand | -598 Thousand | -13 Thousand | -18.39 Thousand | 92.72 Thousand | 481 Thousand |
| Accounts payables | 50.37 Thousand | 1463.00 | 900.00 | 16.25 Thousand | 6712.00 | 50.4 Thousand |
| Inventory | - | 938 Thousand | -59.44 Thousand | 181.44 Thousand | -665.6 Thousand | -481 Thousand |
| Other working capital | -9874.00 | -167.00 | -17.46 Thousand | 37.46 Thousand | -4992.00 | -511.5 Thousand |
| Cash at beginning of period | 95.24 Thousand | 18.12 Thousand | 911.00 | 37.6 Thousand | 36.81 Thousand | 2533.00 |
| Cash at end of period | 5852.00 | 95.24 Thousand | 18.12 Thousand | 911.00 | 1148.00 | 36.81 Thousand |
| Capital Expenditure | 1.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -89.39 Thousand | 77.12 Thousand | 17.21 Thousand | -36.69 Thousand | -35.66 Thousand | 34.27 Thousand |
| Free Cash Flow | -147.48 Thousand | 299.33 Thousand | -199.46 Thousand | -59.7 Thousand | -140.41 Thousand | -463.34 Thousand |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.19 Million | -4 Million | -15.87 Million | -3.93 Million | -4.01 Million | -3.99 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 3.12 Million | 3.92 Million | 15.71 Million | 3.92 Million | 3.92 Million | 3.92 Million |
| Change in working capital | 73.5 Thousand | 69.9 Thousand | 9856.00 | -4774.00 | 29.45 Thousand | -277.44 Thousand |
| Other non-cash items | 789.00 | 788.00 | 1706.00 | 787.00 | 499.00 | 211.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 108.00 | 36.00 | 58.08 Thousand | 232.00 | 57.34 Thousand | 216.00 |
| Debt repayment | -108.00 | -36.00 | -58.08 Thousand | -232.00 | -57.34 Thousand | -216.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 108.00 | 36.00 | 58.08 Thousand | 232.00 | 57.34 Thousand | 216.00 |
| Accounts receivables | 110 Thousand | 30 Thousand | -40.5 Thousand | -360 Thousand | 20 Thousand | -15 Thousand |
| Accounts payables | -40.25 Thousand | 51.21 Thousand | 50.37 Thousand | 55.67 Thousand | -5297.00 | 15 Thousand |
| Inventory | 40.25 Thousand | - | - | 296 Thousand | - | -296 Thousand |
| Other working capital | -36.5 Thousand | -81.21 Thousand | -9874.00 | 3555.00 | 14.75 Thousand | 18.55 Thousand |
| Cash at beginning of period | 322.00 | 5852.00 | 95.24 Thousand | 16.18 Thousand | 12.1 Thousand | 357.66 Thousand |
| Cash at end of period | 2680.00 | 322.00 | 5852.00 | 5852.00 | 16.18 Thousand | 12.1 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 2358.00 | -5530.00 | -89.39 Thousand | -10.33 Thousand | 4081.00 | -345.56 Thousand |
| Free Cash Flow | 2250.00 | -5566.00 | -147.48 Thousand | -10.56 Thousand | -53.26 Thousand | -345.77 Thousand |
ALIT
RCM
6794
KOD
6735
6938